Fidelity Investments’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-2
| Closed | – | – | 5776 |
|
2024
Q4 | $0 | Hold |
2
| – | – | ﹤0.01% | 5872 |
|
2024
Q3 | $4 | Buy |
+2
| New | +$4 | ﹤0.01% | 5456 |
|
2024
Q2 | – | Sell |
-71
| Closed | -$380 | – | 5689 |
|
2024
Q1 | $380 | Buy |
+71
| New | +$380 | ﹤0.01% | 4862 |
|
2023
Q4 | – | Sell |
-346
| Closed | -$1.37K | – | 5698 |
|
2023
Q3 | $1.37K | Buy |
346
+249
| +257% | +$984 | ﹤0.01% | 4606 |
|
2023
Q2 | $306 | Buy |
+97
| New | +$306 | ﹤0.01% | 4869 |
|
2023
Q1 | – | Sell |
-12
| Closed | -$43 | – | 5580 |
|
2022
Q4 | $43 | Sell |
12
-252,017
| -100% | -$903K | ﹤0.01% | 4972 |
|
2022
Q3 | $1.62M | Sell |
252,029
-10,279
| -4% | -$66.2K | ﹤0.01% | 2481 |
|
2022
Q2 | $2.53M | Sell |
262,308
-290,330
| -53% | -$2.79M | ﹤0.01% | 2437 |
|
2022
Q1 | $6.58M | Sell |
552,638
-353,492
| -39% | -$4.21M | ﹤0.01% | 2286 |
|
2021
Q4 | $29.5M | Buy |
906,130
+245
| +0% | +$7.99K | ﹤0.01% | 1639 |
|
2021
Q3 | $40.5M | Buy |
905,885
+1,088
| +0.1% | +$48.6K | ﹤0.01% | 1504 |
|
2021
Q2 | $49.3M | Buy |
904,797
+3,286
| +0.4% | +$179K | ﹤0.01% | 1437 |
|
2021
Q1 | $67.4M | Buy |
901,511
+237,427
| +36% | +$17.8M | 0.01% | 1252 |
|
2020
Q4 | $72.1M | Buy |
664,084
+729
| +0.1% | +$79.1K | 0.01% | 1173 |
|
2020
Q3 | $58.6M | Buy |
663,355
+1,035
| +0.2% | +$91.5K | 0.01% | 1132 |
|
2020
Q2 | $70.6M | Buy |
662,320
+34,422
| +5% | +$3.67M | 0.01% | 1028 |
|
2020
Q1 | $37.2M | Buy |
627,898
+14,357
| +2% | +$851K | 0.01% | 1141 |
|
2019
Q4 | $42.4M | Buy |
613,541
+45
| +0% | +$3.11K | ﹤0.01% | 1280 |
|
2019
Q3 | $63.7M | Buy |
613,496
+52
| +0% | +$5.4K | 0.01% | 1068 |
|
2019
Q2 | $56.8M | Buy |
613,444
+108,628
| +22% | +$10.1M | 0.01% | 1161 |
|
2019
Q1 | $46.1M | Hold |
504,816
| – | – | 0.01% | 1252 |
|
2018
Q4 | $28.1M | Hold |
504,816
| – | – | ﹤0.01% | 1419 |
|
2018
Q3 | $60.1M | Buy |
504,816
+16,141
| +3% | +$1.92M | 0.01% | 1170 |
|
2018
Q2 | $49.9M | Buy |
488,675
+5,766
| +1% | +$589K | 0.01% | 1272 |
|
2018
Q1 | $62.7M | Buy |
482,909
+88,462
| +22% | +$11.5M | 0.01% | 1194 |
|
2017
Q4 | $38.4M | Buy |
394,447
+544
| +0.1% | +$52.9K | ﹤0.01% | 1421 |
|
2017
Q3 | $58M | Buy |
393,903
+1,203
| +0.3% | +$177K | 0.01% | 1238 |
|
2017
Q2 | $63.2M | Buy |
392,700
+41,806
| +12% | +$6.73M | 0.01% | 1193 |
|
2017
Q1 | $55.9M | Buy |
350,894
+187
| +0.1% | +$29.8K | 0.01% | 1254 |
|
2016
Q4 | $42.6M | Buy |
350,707
+91
| +0% | +$11.1K | 0.01% | 1376 |
|
2016
Q3 | $48.6M | Buy |
350,616
+47,887
| +16% | +$6.64M | 0.01% | 1307 |
|
2016
Q2 | $37.8M | Buy |
+302,729
| New | +$37.8M | 0.01% | 1395 |
|